This FTSE 250 stock’s price has doubled. Would I buy it?

The FTSE 250 stock has seen a more than doubling in share price over the last three years. Can it continue to rise further?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Since the last time I wrote about the nanotechnology stock Oxford Instruments (LSE: OXIG) in June, its share price has risen 13%. A largely positive trading update posted yesterday resulted in a 3% increase in its share price from the day before. 

The FTSE 250 nanotechnology company manufactures a range of products used sectors ranging from mining to aerospace. It has a presence across geographies as well, which has held it in good stead over the last year. 

Positive trading update for Oxford Instruments

The company’s latest trading update says that both orders and revenues have shown strong growth in the five months of its current financial year so far. The company now expects trading for the full year to be “slightly” ahead of expectations. It does expect some downside from currency fluctuations, however, which could impact revenue by 4% and operating profit by 3%. While this is a downer, the fact is that it has a limited impact. And in no way does it reflect on the company’s underlying performance. 

In fact, if anything, the latest update continues to add to Oxford Instrument’s ongoing robust performance. Its operating profit had risen by 33% for the full year ending 31 March as well, despite there being no change in its revenue because of the pandemic. 

Rising price for the FTSE 250 stock

It is little wonder then, that the company’s share price has been rising. In the past year alone, it has grown by 54%. This may not sound like a whole lot right now, given the low phase for the stock markets at this time last year. In fact, there are many stocks that show pretty impressive capital gains right now. But Oxford Instruments stands out, because its share price has been rising consistently for a while. In the last three years alone, its share price has more than doubled. 

The challenge to a stock like this is of course that it starts looking pricier than others over time. It has a price-to-earnings (P/E) ratio of 34 times right now. But then its prospects look good too. This indicates to me that there can be room for a share price increase. This is particularly so now that the economy is back. As more growth takes place, there are chances that demand for its products will do so as well. 

Would I buy it?

I have been bullish on the stock for a while now, but have somehow or the other not bought it. It has run up quite a bit since the time I first started writing about it. But it looks like it could rise even further. I maintain that the stock is a good buy for me, and one that I could hold for at least the next few years. 

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Manika Premsingh has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »